GI Onc at Hopkins, focusing on #PancreaticCancer, #PrecisionMedicine. Striving to improve patient outcomes.
Originator of #TumorBoardTuesday @TumorBoardTues
Jan 11 • 21 tweets • 4 min read
#GI25 @ASCO
We're in that gap between the holidays🎄and GI-ASCO (if that matters to you😉)
➡️And, we're stuck here at home because of the snow🌨️ outside
📢So this is a perfect time to present my "Top Abstract Titles" that I will be looking out for🔍at ASCO GI
#GI25 @ASCO
Starting with #PancreaticCancer and Ras⛔️
Actually only2⃣titles I saw:
1⃣@GarridoLagunaMD🗣️ctDNA🩸changes in the Ph1 trial of the Ras(on)⛔️RMC-6236 Abs 722; Poster#H10
2⃣@AlexSpiraMDPhD🗣️a Ph1 trial of the G12D specific⛔️RMC-9805 Abs 724; Poster#H12
Jun 13, 2023 • 22 tweets • 106 min read
@TumorBoardTues@JohnEbbenMDPhD#TumorBoardTuesday
📣Welcome as we summarize some of the incredible data from #ASCO23
👉There was SO much to take in, that even focusing on GI Cancers was a challenge
🙏As always, these were the🧑🏫that caught OUR interest, but this is not a judgement on those we do not highlight‼️
@TumorBoardTues@JohnEbbenMDPhD 1/21 #TumorBoardTuesday
🤔Speaking for myself, @knutjla ‘s data has shaken my practice the most (including twice last week)
👉He presented the NORPACT-1 trial of peri-operative FOLFIRINOX vs. upfront🔪for resectable #PancreaticCancer
Jan 16, 2023 • 21 tweets • 9 min read
😀I am so excited to be at my 1⃣st IN PERSON ASCO GI in 3y
✅To prepare, I have gone through the abstract titles, and here are my Top GI ASCO 2023 abstracts
📣Disclaimer: There is no bias or exclusion intended.
These are just the ones I personally want to see👀 #GI23
➡️Starting with #Cholangiocarcinoma because it is a big year - especially because of:
✅SWOG 1815: A phase III trial of gem-cis-nab-pac vs. gem-cis as 1⃣st line💊for advanced BTC
👁️Rachna Shroff, Abs LBA490 @rachnatshroff
Again,🙏note - I went through a LOT of abstracts, and I definitely may have missed some‼️
👉And these are not in any particular order
✅But enjoy, RT, and reply😀
#ASCO22#PancreaticCancer
🤔Is more better❓
✅Dr. Carrato🧑🏫a Rand trial
👉Gem-nab-pac➡️FOLFOX (sequenced Q6 wks)
vs.
👉Standard Gem-nab-pac
➡️mOS was 3.5mos⬆️with sequenced Tx
➡️Even though more standard pts got 2nd line Tx
🤯Really❓
🤔Interesting
🔎GI Can Oral Abst 4022
He was treated with every other week Gem-nab-pac
🙏@GIcancerDoc
➡️Had rapid symptomatic improvement
➡️Now essentially normal PS
➡️Nice response to treatment for 9 months🙂